CERTOLIZUMAB TROUGH LEVELS AND ANTIBODIES IN INFLAMMATORY BOWEL DISEASE: A SINGLE-CENTER EXPERIENCE

被引：0
|
作者：
Ramos, Guilherme Piovezani
Al-Bawardy, Badr
Willrich, Maria Alice V.
Papadakis, Konstantinos A.
Kane, Sunanda V.
Raffals, Laura H.
Faubion, William
Tremaine, William J.
Loftus, Edward V.
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1855
引用
收藏
页码：S826 / S827
页数：2
相关论文
共 50 条
  • [1] Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience
    Ramos, Guilherme Piovezani
    Al-Bawardy, Badr
    Neto, Manuel Bonfim Braga
    Bledsoe, Adam C.
    Quinn, Kevin P.
    Heron, Valerie
    Willrich, Maria Alice, V
    Johnson, Amanda
    Chedid, Victor G.
    Coelho-Prabhu, Nayantara
    Kisiel, John B.
    Papadakis, Konstantinos A.
    Pardi, Darrell
    Kane, Sunanda
    Tremaine, William J.
    Raffals, Laura
    Bruining, David H.
    Faubion, William A.
    Harmsen, William S.
    Loftus, Edward V., Jr.
    CROHNS & COLITIS 360, 2021, 3 (03)
  • [2] VEDOLIZUMAB TROUGH LEVELS AND ANTIBODIES IN INFLAMMATORY BOWEL DISEASE: UPDATED INITIAL EXPERIENCE
    Al-Bawardy, Badr
    Ramos, Guilherme Piovezani
    Willrich, Maria Alice V.
    Park, Sang
    Raffals, Laura
    Tremaine, William J.
    Loftus, Edward V., Jr.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S62 - S63
  • [3] VEDOLIZUMAB TROUGH LEVELS AND ANTIBODIES IN INFLAMMATORY BOWEL DISEASE: UPDATED INITIAL EXPERIENCE
    Al-Bawardy, Badr
    Ramos, Guilherme Piovezani
    Willrich, Maria Alice V.
    Park, Sang
    Raffals, Laura
    Tremaine, William J.
    Loftus, Edward V., Jr.
    GASTROENTEROLOGY, 2018, 154 (01) : S89 - S89
  • [4] Infliximab Retreatment in Inflammatory Bowel Disease: A Single-center Experience
    Hughes, Julia
    Herfarth, Hans
    Isaacs, Kim
    Plevy, Scott
    Sartor, Balfour
    Sheikh, Shehzad
    Hansen, Jonathan
    Long, Millie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S543 - S543
  • [5] Use of Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience
    Erdogan, Cagdas
    Yesil, Bayram
    Bacaksiz, Ferhat
    Ari, Derya
    Gokbulut, Volkan
    Yuksel, Mahmut
    Ozin, Yasemin Ozderin
    Kayacetin, Ertugrul
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (10): : 831 - 837
  • [6] Cancer surveillance in inflammatory bowel disease: A single-center experience
    Wong, Hang Hoi Michael
    Tze, Ying Ki Shirley
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 130 - 131
  • [7] Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease
    Spencer, Elizabeth A.
    Bergstein, Suzannah
    Dolinger, Michael
    Pittman, Nanci
    Kellar, Amelia
    Dunkin, David
    Dubinsky, Marla C.
    INFLAMMATORY BOWEL DISEASES, 2023, 30 (11) : 2057 - 2063
  • [8] CLINICAL EXPERIENCE WITH VEDOLIZUMAB TROUGH LEVELS IN INFLAMMATORY BOWEL DISEASE
    Al-Bawardy, Badr
    Ramos, Guilherme Piovezani
    Willrich, Maria Alice V.
    Park, Sang Hyoung
    Aniwan, Satimai
    Raffals, Laura H.
    Tremaine, William J.
    Loftus, Edward V.
    GASTROENTEROLOGY, 2018, 154 (06) : S821 - S822
  • [9] Experience with Ustekinumab and Vedolizumab in Inflammatory Bowel Disease Patients: Single-Center Data
    Kandemir, H.
    Karatas, A.
    Moral, K.
    Bilican, G.
    Kekilli, M.
    Cindoruk, M.
    Karakan, T.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1392 - i1393
  • [10] The prevalence of Helicobacter pylori infection and inflammatory bowel disease: A single-center experience
    Cho, Jae Ho
    Lee, Dong Ho
    Shin, Cheol Min
    Song, Dong Jin
    Yoon, Hyuk
    Park, Young Soo
    Kim, Nayoung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 353 - 353
12345